AML is a highly aggressive form of blood cancer in which immature white blood cells rapidly grow out of control, restricting the production of healthy blood cells. Over 2,400 people are diagnosed with AML each year in the ...
Mar 22, 2018
0
2
A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy. The imaging system may be able to predict response to chemotherapy ...
Feb 12, 2018
0
73
Chemicals that attract specialised immune cells toward tumours could be used to develop better immunotherapies for cancer patients, according to new research published in Cell.
Feb 8, 2018
0
4
When people think of leukaemia, they usually think of blood cancers that affect children. These mostly come under the category of acute lymphoblastic leukaemia – or ALL – and are different to the group of blood cancers ...
Jan 16, 2018
0
9
Researchers at the University of Zurich have identified biomarkers in the blood that make it possible to predict whether cancer patients will respond positively to immunotherapy. Pa-tients for whom therapy does not work can ...
Jan 8, 2018
1
272
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...
Nov 17, 2017
0
58
Using newly developed software, researchers have shown that genes and molecular processes in breast cancer tumor cells are tightly linked to genes and processes in blood cells, including immune system cells. The findings ...
Sep 28, 2017
0
3
Researchers from Trinity College Dublin have made a discovery around treatment-resistant breast cancer that may turn the phrase, 'don't shoot the messenger', on its head. The scientists have found that cell to cell messengers ...
Sep 27, 2017
0
176
Cancer cells obtained from a blood test may be able to predict how early-stage lung cancer patients will fare, a team from the University of Michigan has shown.
Aug 30, 2017
0
9
Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.
Jul 14, 2017
0
1
